The estimated impact of state-level support for expanded delivery of substance use disorder treatment during the COVID-19 pandemic.

ABSTRACT:

Background and aims

To prevent COVID-19 transmission, some United States (US) federal regulations on substance use disorder (SUD) treatment were suspended in March 2020. This study aimed to quantify the extent of state-level policy uptake and the potential number of people with SUD affected by these policy changes across the US, as well as to assess if policy uptake correlated with rates of people with SUD already in treatment or needing treatment.

Design

Cross-sectional analysis of policies implemented as of April 13, 2020.

Setting and participants

A total of 50 US states and the District of Columbia MEASUREMENTS: State-level implementation of: oral schedule II controlled substances emergency prescription, extended take-home doses for medication for opioid use disord

SUBMITTER: Nesoff ED 

PROVIDER: S-EPMC9081157 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature